Advertisement
Canada markets open in 3 hours 3 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7311
    +0.0013 (+0.18%)
     

  • CRUDE OIL

    82.85
    +0.04 (+0.05%)
     

  • Bitcoin CAD

    86,839.65
    -3,964.30 (-4.37%)
     

  • CMC Crypto 200

    1,354.65
    -27.93 (-2.02%)
     

  • GOLD FUTURES

    2,337.60
    -0.80 (-0.03%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,499.25
    -165.25 (-0.94%)
     

  • VOLATILITY

    16.15
    +0.18 (+1.13%)
     

  • FTSE

    8,091.07
    +50.69 (+0.63%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6812
    -0.0007 (-0.10%)
     

Company News for Apr 15, 2021

Zacks Equity Research
·1 min read

  • Shares of First Republic Bank FRC rose 1.9% after the reported first-quarter 2021 earnings of $1.79 per share that surpassed the Zacks Consensus Estimate of $1.54.

  • Grupo Televisa, S.A.B.’s TV shares jumped 23.5% after the company reached an agreement with Univision to sell its content and media assets in a deal of $4.8 billion.

  • Shares of Galectin Therapeutics Inc. GALT rose 9% after the company published data from an ongoing Phase 1 trial evaluating Galectin's belapectin in head & neck cancer, lung cancer, and melanoma.

  • Dollar General Corporation’s DG shares rose 0.7% after the company reported that it aims to hire up to 20,000 people at in-person and virtual hiring events that the discount retailer will host.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Grupo Televisa S.A. (TV) : Free Stock Analysis Report
 
First Republic Bank (FRC) : Free Stock Analysis Report
 
Galectin Therapeutics Inc. (GALT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research